Stable analogs of peptide and polypeptide therapeutics

Details Stable analogs of peptide and polypeptide therapeutics Stable analogs of peptide and polypeptide therapeutics

2007-08-21

2007-08-21

Gupta, Anish (Department: 1654)

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

Glucagon; related peptides

C514S002600, C514S012200, C530S324000

Reexamination Certificate

active

10847220

ABSTRACT:
The present invention relates to compositions of peptide and polypeptide analogs that are resistant to proteolysis, pharmaceutical uses thereof, and methods of preparation thereof.

REFERENCES:
patent: 5118666 (1992-06-01), Habener
patent: 5120712 (1992-06-01), Habener
patent: 5276137 (1994-01-01), Ojima et al.
patent: 5545618 (1996-08-01), Buckley et al.
patent: 5614492 (1997-03-01), Habener
patent: 5766620 (1998-06-01), Heiber et al.
patent: 5958909 (1999-09-01), Habener
patent: 5994500 (1999-11-01), Drucker et al.
patent: 6184201 (2001-02-01), Drucker et al.
patent: 6268343 (2001-07-01), Knudsen et al.
patent: 6277819 (2001-08-01), Efendic
patent: 6358924 (2002-03-01), Hoffmann
patent: 6489295 (2002-12-01), Drucker et al.
patent: 2001/0011071 (2001-08-01), Knudsen et al.
patent: 2004/0242853 (2004-12-01), Greig et al.
patent: WO99/40788 (1999-08-01), None
patent: WO99/43705 (1999-09-01), None
patent: WO99/43706 (1999-09-01), None
patent: WO99/43707 (1999-09-01), None
patent: WO 00/07617 (2000-02-01), None
patent: WO 01/98331 (2001-12-01), None
patent: WO 02/22151 (2002-03-01), None
patent: WO 02/46227 (2002-06-01), None
patent: WO 02/47716 (2002-06-01), None
patent: WO 02/069994 (2002-09-01), None
patent: WO 03/002136 (2003-01-01), None
patent: WO 03/018516 (2003-03-01), None
Mentlein et al., “Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36) amide, peptide histidine methionine and is responsible for their degradation in human serum,”European Journal of Biochemistry, 214(3):829-835 (1993).
Deacon et al., “Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity,”Diabetologia, 41(3):271-278 (1998).
Guarita, et al., “PYY Regulates Pancreatic Exocrine Secretion Through Multiple Receptors in the Awake Rat,” Digestive Diseases and Sciences, 2000, vol. 45(9) 1696-1702.
Keire, et al., “Structure and receptor binding of PYY analogs,” Peptides 23 (2002) 305-321.
Mentlein, Rolf, “Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides,” Regulatory Peptides 85 (1999) 9-24.
Naslund, et al., “Glucagon-like peptide-1 analogue LY315902: Effect on intestinal motility and release of insulin and somatostatin,” Regulatory Peptides 106 (2002) 89-95.

Affiliated with

Also associated with

Rating

Stable analogs of peptide and polypeptide therapeutics does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stable analogs of peptide and polypeptide therapeutics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable analogs of peptide and polypeptide therapeutics will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3894903